Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning

Area of Science:

• Cardiovascular Science
• Pharmacology
• Cardiac Surgery

Background:

• Diadenosine tetraphosphate (AP4A) demonstrated cardioprotective effects and mechanisms similar to ischemic preconditioning in rat hearts.
• The study investigated the potential of AP4A in cardiac surgery using a canine cardiopulmonary bypass model.

Purpose of the Study:

• To evaluate the applicability and efficacy of AP4A administration during cardiac surgery.
• To assess the cardioprotective potential of AP4A in a canine cardiopulmonary bypass model.

Main Methods:

• Canine hearts underwent 60 minutes of cardioplegic arrest at 34°C.
• Cardioplegia solutions contained either AP4A (40 µmol/L) or saline (control).
• Left ventricular function was assessed post-reperfusion using cardiac loop analysis.

Main Results:

• AP4A administration significantly enhanced post-ischemic recovery of cardiac function.
• AP4A reduced serum creatine kinase leakage compared to the saline group.
• No significant adverse effects on systemic vascular resistance, blood pressure, or ECG indices were observed.

Conclusions:

• AP4A demonstrated significant cardioprotective effects in a canine model without apparent adverse effects.
• The findings suggest AP4A may be a safe and novel addition to cardioplegia for clinical preconditioning cardioprotection.
• The cardioprotective mechanism of AP4A may align with that of ischemic preconditioning.